Evidence map›Paper›PMID 30868193›Full record

ArticleEuropean journal of clinical pharmacology2019

Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis.

Masayuki Chuma, Makoto Makishima, Toru Imai, Naohiro Tochikura, Shinichiro Suzuki, Tsukasa Kuwana, Nami Sawada, So Iwabuchi, Masao Sekimoto, Takahiro Nakayama and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Masayuki ChumaDepartment of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Makoto MakishimaDivision of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan. makishima.makoto@nihon-u.ac.jp.ORCID http://orcid.org/0000-0002-4630-905X
Toru ImaiDepartment of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Naohiro TochikuraDepartment of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Shinichiro SuzukiDepartment of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Tsukasa KuwanaDivision of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, Tokyo, Japan.
Nami SawadaDivision of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, Tokyo, Japan.
So IwabuchiDepartment of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Masao SekimotoDepartment of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Takahiro NakayamaDepartment of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Takako SakaueDepartment of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Norikazu KikuchiDepartment of Pharmacy, Nihon University Hospital, Tokyo, Japan.
Yoshikazu YoshidaDepartment of Pharmacy, Nihon University Itabashi Hospital, Tokyo, Japan.
Kosaku KinoshitaDivision of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, Tokyo, Japan.
Nihon University Itabashi Hospital · JPNihon University · JPTokushima University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIt is important to accurately estimate accurate vancomycin (VCM) clearance (CLvcm) for appropriate VCM dosing in the treatment of patients with sepsis. However, the pathophysiology of sepsis can make CLvcm prediction less accurate. Clearance of hydrophilic antibiotics is disturbed by organ dysfunction, and hemoglobin levels are negatively correlated with sequential organ function assessment scores. We investigated whether hemoglobin levels are associated with CLvcm in sepsis patients.

methodsWe performed a retrospective cohort study of patients treated with VCM in the Emergency and Critical Care Center of Nihon University Itabashi Hospital between 2005 and 2015. We enrolled 72 patients after exclusion of patients who received renal replacement therapy or surgery, had a change in hemoglobin levels more than 2 g/dL or received an erythrocyte infusion during the interval between initial VCM administration and measurement of initial trough levels, had a serum baseline creatinine level of ≥ 2 mg/dL, or were under 18 years old.

resultsEnrolled patients consisted of 13 non-sepsis patients and 59 sepsis patients. In sepsis patients, although CLvcm was correlated with CrCl in HGB ≥ 9 group as well as in non-sepsis patients, its correlation was not observed in HGB < 9 group. Hemoglobin levels were correlated with CLvcm in sepsis patients but not in non-sepsis patient. Multiple linear regression analysis also indicated that lower CLvcm was associated with lower hemoglobin and CrCl.

conclusionLower hemoglobin levels influence a relationship between CLvcm and CrCl in sepsis patients. We propose that VCM dosing should be adjusted for hemoglobin levels in sepsis patients.

Indexed as

AgedAnti-Bacterial AgentsFemaleHemoglobinsHumansMaleMiddle AgedRetrospective StudiesSepsisVancomycinAnti-Bacterial AgentsHemoglobinsVancomycinHemoglobinSepsisTherapeutic drug monitoringVancomycin clearance

Identifiers

PMID30868193
OpenAlexW2922465964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.